Clinicians analyze long-term efficacy data in psoriasis treatments, focusing on how they communicate and contextualize information about treatment duration to their patients.
Study Compares Dose Escalation with Biologics in Psoriasis
The Cutaneous Connection: An Inside Look of the Inclusive Atlas
Oral Zasocitinib Demonstrates Safety and Efficacy in Moderate to Severe Plaque Psoriasis
The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics
Patients With Psoriasis Demonstrate Higher Rates of Helicobacter Pylori Infection Versus Controls
Higher Risankizumab Adherence with New Injection Device